Other Stories

JW Pharma starts clinical trial in China for gout treatment Updated: 2020-12-02 13:22:10 KST

The Korean firm JW Pharmaceutical is starting clinical trials abroad for its treatment for gout.
Gout is a form of extremely painful inflammation in the joints often afflicting people who are overweight.
The company said Wednesday that its treatment, called arthrifuge, is being tested in China.
40 healthy people will be taking part in the trial at the Shanghai Public Health Clinical Center.
The company has already started a trial in South Korea with 140 participants, which it says is so far successful.
The next phase is underway, with results due out early next year.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.